Albireo Pharma Inc
Change company Symbol lookup
Select an option...
ALBO Albireo Pharma Inc
XMTR Xometry Inc
STX Seagate Technology Holdings PLC
HYHG.EU ProShares High Yield-Interest Rate Hedged
DIDIY DiDi Global Inc
AWK American Water Works Company Inc
ASO Academy Sports and Outdoors Inc
GAB Gabelli Equity Trust
STRC Sarcos Technology and Robotics Corp
RLMD Relmada Therapeutics Inc

Health Care : Biotechnology | Small Cap Growth
Company profile

Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its product, Bylvay, is for the treatment of pruritis in patients with progressive familial intrahepatic cholestasis (PFIC) ages three months or older and is authorized in Europe for the treatment of PFIC in patients ages six months or older. Its product candidate elobixibat is licensed for the treatment of chronic constipation and other functional diseases in Japan and other select markets in Asia. Its lead candidate for adult liver diseases, A3907, is a selective inhibitor of the apical sodium-dependent bile acid transporter (ASBT) where systemic bioavailability has been demonstrated in preclinical and clinical studies. Its preclinical candidate for adult viral and liver diseases includes A2342.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    4:00p ET 09/27/22
  • Last (size)
  • 52-Wk Range
    16.02 - 37.63
  • (04/13/22 - 09/07/22)
  • 72.2%
  • Market Cap
  • Shares Outstanding
  • -1.89
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 95.75
  • (% of float 09/15/22)

Latest News

September 27, 2022
4:30 pm ET
Globe Newswire
September 22, 2022
8:30 am ET
Globe Newswire
September 20, 2022
8:00 am ET
Globe Newswire
September 06, 2022
8:00 am ET
Globe Newswire
September 01, 2022
8:00 am ET
Globe Newswire
August 22, 2022
5:13 pm ET
Globe Newswire
August 15, 2022
4:05 pm ET
Globe Newswire
August 10, 2022
8:30 am ET
Globe Newswire
August 03, 2022
8:30 am ET
Globe Newswire
August 01, 2022
2:04 pm ET
Globe Newswire
July 26, 2022
4:30 pm ET
Globe Newswire
July 06, 2022
8:30 am ET
Globe Newswire
June 30, 2022
8:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.